We have shown previously that Bcl-XS causes acute cell death in 3T3 cells w
ithout activating caspases (Fridman, J. S,, Benedict, M. k, and Maybaum, J.
(1999) Cancer Res. 59, 5999-6004). In this study, we determined that the e
xplanation for lack of caspase activation is the cellular depletion of cyto
chrome c. Electron microscopy revealed gross structural changes in the mito
chondria of Bcl-XS-expressing cells; however, cytochrome c was not detected
in cytosolic fractions from these cells. Surprisingly, it was determined t
hat cellular cytochrome c levels decreased as Bcl-XS expression levels incr
eased. Experiments performed to eliminate other possible explanations for t
he lack of caspase activation showed that these 3T3 cells have a functional
cytoplasmic apoptosome, a complex of proteins that form a functional trigg
er capable of activating the proximal caspase in an apoptotic pathway Chinn
aiyan, k M. (1999) Neoplasia 1, 5-15, as cytosolic extracts from these cell
s were capable of cleaving pro-caspase-9. These cells were also able to rel
ease cytochrome c from their mitochondria after appropriate stimulation, ot
her than Bcl-XS expression (i.e. withdrawal from serum for 24 h), and initi
ate a cell death that is inhibited by a dominant negative caspase-9. We con
clude that lack of caspase activation is due to a Bcl-XS-induced depletion
of active cytochrome c, a phenomenon that represents an alternative cell de
ath effector pathway and/or a novel mechanism for regulating caspase activa
tion.